Two Sigma Securities, LLC Clovis Oncology, Inc. Transaction History

Two Sigma Securities, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.85 $13,974 - $37,930	13,309 Added 104.43%	26,054 $31,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $43,657 - $205,119	-69,297 Reduced 84.47%	12,745 $23,000
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $65,944 - $144,801	46,115 Added 128.36%	82,042 $166,000
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $47,538 - $83,809	17,607 Added 96.11%	35,927 $97,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $88,302 - $141,430	18,320 New	18,320 $107,000
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $110,719 - $432,455	-28,173 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $360,896 - $723,200	28,173 New	28,173 $419,000
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $208,140 - $356,880	-11,786 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $137,071 - $385,048	11,786 New	11,786 $212,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.